ARTV

NASDAQStock

Artiva Biotherapeutics, Inc.

$6.12-0.63 (-9.33%)

52-Week Range

$1.47

$7.13

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

2.19

Volume

193.0K

Avg Volume

219.8K

Performance

+68.75%

+7.14%

+184.81%

YTD

+59.57%

+14.99%

-43.75%

Price Chart

ETF Exposure

ARTV is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SURI	Simplify Propel Opportunities ETF	0.21%	23,230	$157K	$76.9M	2.82%
IWC	iShares Micro-Cap ETF	0.01%	11,006	$78K	$1.27B	0.60%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	3,029	$20K	$2.68B	0.14%
DFAS	Dimensional - US Small Cap ETF	0.00%	678	$5K	$12.65B	0.26%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	7	$38	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	260	$1K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$6	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	148,199	$576K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	779	$4K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	67	$354	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	59,487	$231K	$84.10B	0.05%

About ARTV ETF Exposure

Artiva Biotherapeutics, Inc. (ARTV) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.12. Investors can gain exposure to ARTV through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ARTV, sorted by portfolio weight.